Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

University of Dundee announces £5m research centre to create 25 jobs

Artist’s impression of the Centre for Targeted Protein Degradation.
Artist’s impression of the Centre for Targeted Protein Degradation.

University of Dundee plans to create 25 jobs with a £5 million specialist research centre.

It will create a Centre for Targeted Protein Degradation (CeTPD) to bolster the university’s “world-leading position in a field of chemical biology”.

The research centre to be housed at the Technopole site adjacent to Dundee’s School of Life Sciences.

The existing two-storey building will be fitted out with state-of-the-art facilities.

The university has launched a fundraising campaign for the investment will be met by a mixture of public and private sources as well as University funds.

What research will be carried out?

These will allow Professor Alessio Ciulli and colleagues to expand their pioneering work in an area that has attracted billions of pounds of investment globally.

The core team working on targeted protein degradation (TPD) at the University will grow from around 25 staff currently to 50 people when their labs are relocated to the new centre.

Targeted protein degradation co-opts a cell’s natural disposal systems to remove disease-causing proteins.

Artist’s impression of Centre for Targeted Protein Degradation.

As an entirely new approach, it provides hope of treating diseases previously thought to be resistant to drugs. The first degrader drugs of these kind are advancing in clinical trials against cancer.

Amphista Therapeutics, the University spin out Professor Ciulli founded, last month received a near-£40 million investment to further its work developing new drugs for a range of diseases.

“Targeted protein degradation is one of the most exciting areas of scientific study to have emerged in many years, one which is revolutionising drug development,” he said.

“We are only beginning to explore the true potential of TPD to produce next-generation therapeutics for a variety of diseases.

The University of Dundee has a formidable reputation in life sciences.

“Dundee is right at the heart of these efforts. We are one of a handful of institutions leading the world in TPD and this Centre is integral to our ambition of establishing Dundee as the undisputed pinnacle for training and innovating in TPD research.

“Our new home will provide opportunities for growth and to capitalise on the expertise we have established here.

“It will help to accelerate innovation and will also attract further investment and major collaboration partners in the pharmaceutical industry.”

Tay Cities Deal funding

Promoting further commercialisation is a key aim of Centre for Targeted Protein Degradation, which will be sited next to the new Tay Cities Regional Innovation Hub.

This facility, funded as part of the Tay Cities Deal, will bring together world-class life sciences innovation and entrepreneurial expertise to drive high-growth company formation, providing new treatments and technologies.

The CeTPD is expected to contribute to a pipeline of spinout companies translating exceptional fundamental research into products that benefit patients across the world and underpin successful commercial entities.

Professor Iain Gillespie, principal and vice-chancellor of the University, said: “This development is pivotal to our ambition for Dundee to establish itself not just as a great place for scientific discovery which subsequently drives economic growth elsewhere but also as a leading location for us to grow the businesses we spin out and to create a vibrant bio-cluster here in Tayside.

Professor Iain Gillespie.

“The investment we are making demonstrates our commitment to supporting and nurturing excellence, with the work of Professor Ciulli and colleagues truly leading the world in terms of TPD research.

“The industry partnerships that have subsequently developed have been heralded as exemplary by the pharmaceutical companies we work with. We are very excited by the prospect of the CeTPD helping to realise the scientific and commercial potential of this field and of our city.”

Work to fit out the Centre is already underway and is expected to be completed by early 2022.

Already a subscriber? Sign in